Nasopharyngeal carcinoma patients using chemotherapy Nedaplatin observation and nursing of allergic reactions.doc

 PAGE \* MERGEFORMAT 7 Nasopharyngeal carcinoma patients using chemotherapy Nedaplatin observation and nursing of allergic reactions [Abstract] author via the 85 patients with advanced nasopharyngeal cancer patients in the use of chemotherapeutic agents during chemotherapy Nedaplatin observations and found that there are five cases of patients developed allergic reactions, because of the timely given the appropriate treatment and care, there is no complication . Prompted the use of nurses in the course of nedaplatin chemotherapy should be closely observed, identify problems and timely treatment in order to ensure patient safety. [Keywords:] nasopharyngeal carcinoma patients with allergic reaction to chemotherapy drugs Nedaplatin Observation Care The current treatment of patients with advanced nasopharyngeal carcinoma with radiotherapy mainly used, in conjunction with chemotherapy (induction chemotherapy, radiotherapy and chemotherapy over the same period, adjuvant chemotherapy), and symptomatic supportive care and other comprehensive treatment approach, aimed at improving local control rate of patients, clinical cure rate and prolong the patient’s quality of life. Nida is the second generation of organic platinum antitumor platinum drugs, the chemical name cis - glycolic acid - diamine-platinum, for cisplatin analogues. With cis-platinum in the same way with the DNA binding, and inhibit DNA replication, resulting in anti-tumor activity [1], its indications are head and neck cancer, non-small cell lung cancer, small cell lung cancer, esophageal cancer, bladder cancer, ovarian cancer and other solid tumors, adverse reactions are mainly bone marrow suppression, nausea, vomiting, liver and kidney dysfunction, even cause allergic reactions. According to reports in the 0.1-5% incidence of allergic reactions. But the authors used in the clinical course of nedaplatin appears in allergic reactions, even severe anaphylactic shock reactions. Therefore, the use of nedap